Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality Home
BiotechReality – Information Intelligence System for Biopharma
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#Eli Lilly and Company #Johnson&Johnson #Clinical Data #Quarterly Results #FDA Approval #Phase 3 Trials #Novo Nordisk #Cancer

Category: News

News

First person who received the genetically modified pig kidney died after two months

  • By Achuth B S
  • 12 May 2024
pig kidney transplants

The xenotransplantation technology of biotechnology is used for transplantation.

Tagged Xenotransplantation
Research News

A new way, that could lead to universal, long-lasting flu shot

  • By Journal Updates
  • 10 May 2024
duke university flu shot

This novel vaccination strategy is part of a five-year-old endeavour to create a more durable, universal flu vaccine that can thwart all viral strains

Tagged Flu-Shot, Influenza
Research Disease Biology News

An experimental monoclonal antibody drug called mAb43 can protect pancreas cells from immune system attack

  • By Editor's Desk
  • 9 May 2024
beta cells in pancreas

The drug is special, say the researchers, since it specifically targets the beta cells in the pancreas that produce insulin and is made to protect those cells against the immune system attacks.

Tagged Diabetes, mAb
Science News

Researchers found evidence that orangutan treats wounds with pain-relieving plant

  • By Achuth B S
  • 5 May 2024
orangutan treat wound

The great apes, who are the closest living ancestors of humans, are known to apply plant material topically to relieve painful muscles and to consume certain plants to cure parasite infections.

Tagged Orangutan, Self-Treatment
Genetics Disease Biology News

Progression of amyotrophic lateral sclerosis (ALS) can be slowed down by a new gene therapy

  • By Journal Updates
  • 4 May 2024
amyotrophic lateral sclerosis

Researchers at Umeå University demonstrate that a novel gene treatment has significantly slowed down the disease development in a patient with an extremely severe type of ALS illness.

Tagged Amyotrophic Lateral Sclerosis, Gene Therapy
Genomics News Technology

Single Cell Atlas; a pioneer for biomedical research

  • By Editor's Desk
  • 29 April 2024
Single Cell Atlas

The goal is to produce an essential instrument that will assist researchers globally in understanding more about human health and illness.

Tagged Biomedical Research, Genome Biology, Single Cell Atlas
Diagnostic Tests News

Prostate cancer can be detected by a urine test

  • By Editor's Desk
  • 24 April 2024
urine test for prostate cancer

The test, which examines 18 genes, was created especially to identify malignancies that require rapid treatment as opposed to those that grow slowly.

Tagged Prostate Cancer, Urine Test
Healthcare & Pharmaceuticals News

FDA-approved epilepsy drug prevents brain tumors in mice with NF1

  • By Journal Updates
  • 18 April 2024
epilepsy brain

Research establishes foundation for clinical experiment targeted at averting brain tumours in kids with NF1.

Tagged Brain Tumors, Epilepsy, FDA
Research News

Reduced risks of common diseases through the inherited predisposition for higher muscle strength

  • By Editor's Desk
  • 16 April 2024
muscle strength

An extended life expectancy and a reduced risk of common diseases are predicted by a genetic inclination towards greater muscle strength

Tagged Disease Risks, Muscle Strength
Disease Biology News

A new theory for Parkinson’s disease origin and spread

  • By Editor's Desk
  • 14 April 2024
parkinson's disease

On World Parkinson’s Day, a new hypothesis study combines the body-first and brain-first theories with environmental toxicants that may be consumed or breathed as potential origins of the condition.

Tagged Parkinson's disease

Posts navigation

← Older Posts
→ Newer Posts
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

Merck KGaA Q3 2026 Results: Pimjetmi FDA Approval and Silence Therapeutics Deal Back a Raised Full-Year Outlook
Business Life Sciences News

Merck KGaA Q3 2026 Results: Pimjetmi FDA Approval and Silence Therapeutics Deal Back a Raised Full-Year Outlook

12 November 202612 November 2026
BiotechReality Business Intelligence Desk
Novartis Rhapsido CIndU Data: Remibrutinib Shows Sustained Efficacy Through Week 52 in Phase III RemIND Study
Clinical Data Healthcare & Pharmaceuticals News

Novartis Rhapsido CIndU Data: Remibrutinib Shows Sustained Efficacy Through Week 52 in Phase III RemIND Study

12 November 202612 November 2026
Clinical Trials & Data Desk
Amgen Dazodalibep Phase 3 OASIZ-301 Results Show Systemic Disease Activity Gains in Sjögren’s Disease
Clinical Data Healthcare & Pharmaceuticals News Rare Diseases

Amgen Dazodalibep Phase 3 OASIZ-301 Results Show Systemic Disease Activity Gains in Sjögren’s Disease

12 November 202612 November 2026
Clinical Trials & Data Desk
Novo Nordisk World Diabetes Foundation Commitment: Pledges USD 200 Million for Diabetes Prevention and Care, 2027–2036
Diabetes Business Healthcare & Pharmaceuticals News

Novo Nordisk World Diabetes Foundation Commitment: Pledges USD 200 Million for Diabetes Prevention and Care, 2027–2036

11 November 202611 November 2026
BiotechReality Business Intelligence Desk
Charles River Frontage Acquisition: Charles River Laboratories to Buy Frontage’s Bioanalysis and DMPK Businesses for About $470 Million
Merger & Acquisitions Healthcare & Pharmaceuticals News

Charles River Frontage Acquisition: Charles River Laboratories to Buy Frontage’s Bioanalysis and DMPK Businesses for About $470 Million

9 November 20269 November 2026
BiotechReality Business Intelligence Desk
Eli Lilly and Company’s Foundayo Sleep Apnea Phase 3 ATTAIN-OSA Results Show Up to 44% Fewer Breathing Interruptions
Clinical Data Clinical Trials Healthcare & Pharmaceuticals News Weight-loss Drugs

Eli Lilly and Company’s Foundayo Sleep Apnea Phase 3 ATTAIN-OSA Results Show Up to 44% Fewer Breathing Interruptions

9 November 20269 November 2026
Clinical Trials & Data Desk
Advertisement
BiotechReality JobFinder

  • Global Clinical Supply Business Support Coordinator – Pfizer, Makati
    9 November 2026
  • Senior Product Analyst – Novartis, India
    25 October 2026
  • Rare Disease Medical Science Liaison (MSL) – Amgen, Japan
    20 October 2026
  • Clinical Project Management Director – IQVIA
    16 October 2026
  • Senior Manager, Global Digital Marketing – Lonza
    11 October 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter